BTA 0.00% 57.0¢ biota holdings limited

research data sankyo tjw, page-5

  1. dma
    4,618 Posts.
    TJW, I was thinking about what you said about GSK changing the Inhaler to a more User friendly version and came across some information, that GSK are in collaborations with Ranbaxy and have been for years and they have an Inhaler they could have used and I wouldn,t be surprised if that is where GSK were making IV Relenza, we will know pretty soon, I think they could be the 3rd party Biota are talking about in their presentation. You know they may have a new Inhaler, just waiting in the wings waiting for a settlement?

    http://72.14.253.104/search?q=cache:1zv-VHk-4QkJ:www.ibef.org/download/Pharma_sectoral.pdf+Ranbaxy+and+GSK+extend+R+%26+D+ties&hl=en&ct=clnk&cd=10&gl=au

    Cheers dma
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.